Open AccessJournal Article
Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.
4.3K
About: This article is published in The European respiratory journal. Supplement. The article was published on 01 Mar 1993. and is currently open access. The article focuses on the topics: Lung volumes.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients.
TL;DR: Using lung function tests on their own with 80% predicted and fixed cut points to determine whether a test is abnormal could misdiagnose > 20% of patients referred for pulmonary function tests.
226
Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients.
Vincent Cottin,Thierry Chinet,Armelle Lavolé,Romain Corre,Eric Marchand,Martine Reynaud-Gaubert,Henri Plauchu,Jean-François Cordier +7 more
TL;DR: A high frequency of CNS and infectious complications was observed in this large series of patients with HHT-related PAVM and systematic screening for PAVM should be proposed, regardless of a patient's symptoms, familial history, or genetic considerations.
222
Prevalence and Impact of Bronchiectasis in α1-Antitrypsin Deficiency
TL;DR: The computed tomographic phenotype of 74 subjects with AAT deficiency was characterized, using visual scoring of airway disease and densitometric assessment of emphysema, and a subgroup with a bronchiectasis-predominant phenotype was identified.
222
Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone.
TL;DR: It is concluded that single inhaler therapy with budesonide and formoterol is a clinically effective and well-tolerated treatment for patients with asthma that is not fully controlled by inhaled glucocorticosteroids alone.
221
Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
Joseph Muenzer,Michael Beck,Christine M. Eng,Roberto Giugliani,Paul Harmatz,Rick A. Martin,Uma Ramaswami,Ashok Vellodi,James E. Wraith,Maureen Cleary,Muge Gucsavas-Calikoglu,Ana Cristina Puga,Marwan Shinawi,Birgit Ulbrich,Suresh Vijayaraghavan,Susanne Wendt,Anne Marie Conway,Alexandra Rossi,David A.H. Whiteman,Alan Kimura +19 more
TL;DR: In this paper, the safety and effectiveness of long-term enzyme replacement therapy with idursulfase (recombinant human iduronate-2-sulfatase) in patients with Hunter syndrome was evaluated.
221
Related Papers (5)
Martin R. Miller,John L. Hankinson,Vito Brusasco,Felip Burgos,Richard Casaburi,Allan L. Coates,Robert O. Crapo,Paul L. Enright,C.P.M. van der Grinten,P. Gustafsson,R. Jensen,D.C. Johnson,Neil R. MacIntyre,Roy T. McKay,Daniel Navajas,O. F. Pedersen,Riccardo Pellegrino,Giovanni Viegi,J. Wanger +18 more